We offer the following services to support your company with quality-, law- and regulatory-based challenges in the field of medical devices.
Peercode’s Atris is a telemonitoring system that can be used to gain further insight into the (movement) patterns of (revalidating) patients for both the patients and physicians.
More about AtrisIMID monitor is a software application that supports patients with rheumatoid arthritis and inflammatory diseases in the clinical environment/setting.
More about IMID-monitorMASK-air is an application created for people with allergies and asthma. It helps patients keep track of their symptoms and medication use and sends a notification when certain limits are exceeded.
More about MASK-airOur ambition is to assist customers with bringing and keeping innovative medical devices to market. Our clients vary from startups and small businesses to large mutli-nationals.
“Peercode’s project assistance, clinical writing and quality review was of tremendous value for our clinical trial submission. In particular the advises given and the added knowledge on the MDR requirements has made a difference.
We feel we went through a great learning experience with a great outcome. We would recommend Peercode to anyone when seeking Medical Device consultancy.”
Aylvin Dias, Principal Scientist & Project Lead – Implant trial DSM
Medical devices have a direct impact on people’s health and the quality of care they receive from healthcare providers. For that reason, the medtech industry is tightly wrapped in regulation, and a product’s quality and correct usage are paramount.
Legislation like the EU’s Medical Device Regulation (MDR) is there to enforce consistent and stringent standards for all. But, for medtech companies bringing products to multiple markets, it adds to a labyrinth of legislation. Here are our expert tips for navigating it.
For medical device manufacturers, getting started with the EU’s Medical Device Regulation (MDR) is a huge challenge. With over 120 articles, close to 20 annexes, and more than 200 pages – plus all the accompanying guidance documents – it’s an enormous regulation to decode.
Not only is it vast, the MDR also continuously evolves alongside the state of the art, new standards, and related regulations (such as the AI Act). Even for experienced compliance professionals, it can be a challenge to correctly decipher the MDR.
To help you get started, here’s our outline of the best starting point for medical device manufacturers to dive into the MDR.
2023 saw a number of important updates and amendments to the EU’s Medical Device Regulation (MDR). Medical device companies will continue to feel the impact of these changes into 2024 and beyond.
Digital Therapeutics (DTx) are evidence-based therapeutic interventions that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. There lie many opportunities in the integration of DTx in the current health care system. There are several ways in which the DTx can generate value and the working method differs largely between products. As the number of patients with chronic illnesses grow over time and the future global digital therapeutics market size is predicted to continue to grow, the need for pharmaceutical companies to shift their focus towards DTx increases.
Peercode Regulatory Consultancy is part of Peercode. Visit the Peercode website to get an overview of all our services. The Peercode Regulatory Consultancy team introduces itself here:
The new Medical Device Regulation (MDR) ensures that the emphasis is on patient safety, but also entails a lot of additional requirements. We have experienced ourselves from Peercode what this process entails for software products. Based on our own experience in marketing medical devices, we like to support other companies in this process. That is why we have a Peercode Regulatory Consultancy branch within Peercode, where we combine our personal experience and the experience of Peercode to help our customers. We are a small company and like a pragmatic approach. Thinking from the product and the existing processes and translating this into good documentation at both process and product level. We are happy to offer support to allow a system to grow, after which the customer is aware of all regulations and quality requirements and can put an innovative product on the market.
Innovation is in our code. Since 1999, we have developed software solutions for clients such as: KLM, Robeco, Police, Fire Brigade, Arbo Unie, Erasmus MC, Pfizer, Meda Pharmaceuticals, Ministry of Justice and UMC Groningen.
In the area of health and movement we have 3 products, software as medical device, on the market under the MDR.
Peercode consists of an experienced group of professionals in the area of software engineering, web design, user experience design, CE registration, (cognitive) ergonomics and app development.
We help you convert your knowledge and ideas in the area or lifestyle and health into inspiring websites and (mobile) applications. By means of a sophisticated design, storytelling and scientific research, we translate your creative ideas into effective applications.
Peercode was founded in 1999 and started under the name in2sports. On 1 November 2012, this name was changed to Peercode. The reason for this name change was due to the fact that, in addition to the domain of sport and health promotion, more and more clients also have and implement projects in the medical domain. The name ‘in2sports’ raised questions about that and also had confusing associations.
The name Peercode is a combination of the words “Peer” and “Code”: “code” referring to software development, which is an important part of the company, and “peer” which is also strongly associated with the web/computers (peer-to-peer, peer review, etc.).
But also:
Peercode currently has a balanced team of experienced professionals from various fields, such as management, marketing and sales, software architecture, web design, (cognitive) ergonomics and sport and health. Peercode has further developed over the past years and is now also active on the international market.
See also this page in Dutch.